Quality assurance in the EORTC trial 22991: the dummy run

被引:0
|
作者
Ataman, F
Poortmans, P
Giraud, J
Davis, J
Maingon, P
Conil, M
Van den Bergh, F
Bolla, M
机构
[1] Eortc Data Ctr, Brussels, Belgium
[2] Dr Bernard Verbeeten Inst, Tilburg, Netherlands
[3] CHU Grenoble, F-38043 Grenoble, France
[4] Univ Spital Zurich, Zurich, Switzerland
[5] Ctr Georges Francois Leclerc, Dijon, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S414 / S414
页数:1
相关论文
共 50 条
  • [21] Quality assurance of radiotherapy in the ongoing EORTC 22042–26042 trial for atypical and malignant meningioma: results from the dummy runs and prospective individual case Reviews
    Mehtap Coskun
    William Straube
    Coen W Hurkmans
    Christos Melidis
    Patricia F de Haan
    Salvador Villà
    Sandra Collette
    Damien C Weber
    Radiation Oncology, 8
  • [22] Quality assurance in EORTC clinical trials
    Marinus, A
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S159 - S161
  • [23] QUALITY ASSURANCE IN RADIOTHERAPY: THE EORTC EXPERIENCE
    Weber, D.
    Hurkmans, C.
    Melidis, C.
    Teglas, V.
    Lacombe, D.
    Gregoire, V.
    RADIOTHERAPY AND ONCOLOGY, 2012, 102 : S182 - S183
  • [24] Dummy run and conformity indices in the ongoing EORTC low-grade glioma trial 22033-26033: First evaluation of quality of radiotherapy planning
    Musat, Elena
    Roelofs, Erik
    Bar-Deroma, Raquel
    Fenton, Paul
    Gulyban, Akos
    Collette, Laurence
    Stupp, Roger
    Weber, Damien C.
    Davis, J. Bernard
    Aird, Edwin
    Baumert, Brigitta G.
    RADIOTHERAPY AND ONCOLOGY, 2010, 95 (02) : 218 - 224
  • [25] Quality assurance of radiotherapy in the ongoing EORTC 22042-26042 trial for atypical and malignant meningioma: results from the dummy runs and prospective individual case Reviews
    Coskun, Mehtap
    Straube, William
    Hurkmans, Coen W.
    Melidis, Christos
    de Haan, Patricia F.
    Villa, Salvador
    Collette, Sandra
    Weber, Damien C.
    RADIATION ONCOLOGY, 2013, 8
  • [26] Quality assurance in head and neck surgical oncology: EORTC 24954 trial on larynx preservation
    Leemans, C. R.
    Tijink, B. M.
    Langendijk, J. A.
    Andry, G.
    Hamoir, M.
    Lefebvre, J. L.
    EJSO, 2013, 39 (09): : 1013 - 1018
  • [27] EORTC External Quality Assurance Program for ER and PgR measurements: Trial 1998/1999
    Sweep, CGJ
    Geurts-Moespot, J
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2000, 15 (01): : 62 - 69
  • [28] Quality assurance of 4DCT in the EORTC Lungtech trial on SBRT for patients with NSCLC
    Lambrecht, M.
    Sonke, J. J.
    Nestle, U.
    Peulen, H.
    Weber, D.
    Verheij, M.
    Hurkmans, C. W.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S532 - S533
  • [29] POSTOPERATIVE INTENSITY MODULATION RADIOTHERAPY (IMRT) FOR ENDOMETRIAL CANCER: RESULTS OF THE QUALITY ASSURANCE PROGRAM "DUMMY RUN" OF THE PHASE 2 RTCMIENDOMETRE FRENCH MULTICENTRE TRIAL
    Kreps, S.
    Barillot, I.
    Peignaux, K.
    Nickers, P.
    Leblanc-Onfroy, M.
    Williaume, D.
    Haie-Meder, C.
    Lerouge, D.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : XI - XI
  • [30] Acute toxicity of curative radiotherapy for intermediate risk localized prostate cancer in the EORTC trial 22991
    Matzinger, O.
    Duclos, F.
    van den Bergh, A.
    Carrie, C.
    Kitsios, P.
    Villa, S.
    Poortmans, P.
    Sundar, S.
    Collette, L.
    Bolla, M.
    EJC SUPPLEMENTS, 2009, 7 (02): : 151 - 152